Clinical Trials on MTAP-null Solid Tumors in Canada
Total 365 results
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
University of AlbertaWithdrawnLocally Advanced Solid Tumors | Metastatic Solid TumorsCanada
-
University Health Network, TorontoCompleted
-
University Health Network, TorontoNuBiyotaActive, not recruiting
-
Bristol-Myers SquibbCompletedAdvanced Solid Tumors | Metastatic Solid TumorsKorea, Republic of, Canada, Australia
-
University Health Network, TorontoBoehringer IngelheimCompleted
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
University Health Network, TorontoRecruitingSolid Tumors and Metastatic LesionsCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedSolid Tumors With Oligometastatic SpreadCanada
-
Regeneron PharmaceuticalsSanofiCompleted
-
AstraZenecaActive, not recruitingSolid TumorsUnited Kingdom, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Sunnybrook Health Sciences CentreUniversity of Toronto; Princess Margaret Hospital, CanadaRecruiting
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedAdvanced Solid TumoursCanada
-
AstraZenecaCompletedAdvanced Solid TumorsDenmark, Canada
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Belgium, Denmark, Canada
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Japan, Canada
-
University Health Network, TorontoRecruiting
-
University Health Network, TorontoActive, not recruiting
-
Boehringer IngelheimRecruitingSolid TumorsSpain, Canada, United States, Sweden
-
Gilead SciencesRecruitingSolid TumorsAustralia, United States, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
Bristol-Myers SquibbCompletedCancer (Solid Tumors)United Kingdom, United States, Canada
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom
-
SignalChem Lifesciences CorporationCompleted
-
Daiichi Sankyo Co., Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerJapan, United States, Canada
-
Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, Canada, Switzerland
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...TerminatedAdvanced Solid TumorsUnited States, Canada
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
Regeneron PharmaceuticalsSanofiCompletedSolid TumorsUnited States, Canada
-
Welichem Biotech Inc.Ozmosis Research Inc.Completed
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Australia, Belgium, Denmark, Canada
-
Hoffmann-La RocheRecruitingSolid TumorsBelgium, Denmark, Spain, Canada, Netherlands, Poland
-
Jewish General HospitalNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Netherlands, Denmark, Spain, Canada, France
-
YM BioSciencesCIMYM BioSciencesCompleted
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Belgium, Denmark, Canada, Australia
-
Novartis PharmaceuticalsCompletedA Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsSolid TumorsSpain, Italy, United States, Canada
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Hoffmann-La RocheCompleted
-
NCIC Clinical Trials GroupS*BIOCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Eli Lilly and CompanyActive, not recruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, France, Australia, Belgium, Germany, Spain, Italy
-
Ankyra Therapeutics, IncRecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Malignant Solid Tumor | Cutaneous Tumor | Subcutaneous Tumor | Metastasis to Soft TissueUnited States, Canada
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
GlaxoSmithKlineNot yet recruitingSolid TumorsUnited States, Canada, Australia
-
Novartis PharmaceuticalsCompletedSolid TumorsSpain, Canada, France, Denmark, Netherlands, Germany, Norway